華興資本(01911.HK)批出1億美元預算 未來兩年發展Web3.0業務和投資加密貨幣資產
華興資本(01911.HK)公布,董事會決議在穩固華興現有業務的同時,進軍Web3.0和加密貨幣資產領域,並批准總額為1億美元的預算,在未來兩年期間用於集團發展Web3.0業務和投資加密貨幣資產。
集團認為,Web3.0及加密貨幣資產具有巨大的未來發展潛力,符合全球金融和商業發展的趨勢。在集團基金成功投資了Circle Internet Group,以及為眾多加密貨幣龍頭企業完成了上市及多輪融資相關服務的基礎上,集團將加大對穩定幣、RWA(現實世界資產)以及圍繞加密貨幣全鏈條生態系統的投入及發展力度,並積極拓展相關業務牌照的申請和升級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.